TY - JOUR T1 - Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 871 LP - 877 DO - 10.2967/jnumed.116.182873 VL - 58 IS - 6 AU - Eric A. Osborn AU - Chase W. Kessinger AU - Ahmed Tawakol AU - Farouc A. Jaffer Y1 - 2017/06/01 UR - http://jnm.snmjournals.org/content/58/6/871.abstract N2 - Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment. ER -